10.07.2015 Views

Heparins and mechanical methods for thromboprophylaxis in ...

Heparins and mechanical methods for thromboprophylaxis in ...

Heparins and mechanical methods for thromboprophylaxis in ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

References to studies await<strong>in</strong>g assessmentAdolf 1989Adolf J, Knee H, Roder JD, van de Flierdt E, Siewert JR. Thromboembolismprophylaxis with low molecular weight hepar<strong>in</strong> <strong>in</strong> abdom<strong>in</strong>alsurgery. Dtsch Med Wochenschr 1989;114:48–53.Bergqvist 1980Bergqvist D, Efs<strong>in</strong>g HO, Hallbook T, L<strong>in</strong>dblad B. Prevention ofpostoperative thromboembolic complications. A prospective comparisonbetween dextran 70, dihydroergotam<strong>in</strong>, hepar<strong>in</strong> <strong>and</strong> a sulphatedpolysaccharid. 146. Acta Chir Sc<strong>and</strong> 1980;556:559–68.Bergqvist 1990 ABergqvist D, Burmark US, Frisell J, Guilbaud O, Hallbook T, HornA, et al. Thromboprophylactic effect of low molecular weight hepar<strong>in</strong>started <strong>in</strong> the even<strong>in</strong>g be<strong>for</strong>e elective general abdom<strong>in</strong>al surgery: acomparison with low-dose hepar<strong>in</strong>. Sem<strong>in</strong> Thromb Hemost 1990;16Suppl:19–24.Bergqvist 1986 ABergqvist D. Low molecular weight hepar<strong>in</strong> once daily comparedwith conventional low-dose hepar<strong>in</strong> twice daily. A prosepctive double-bl<strong>in</strong>dmulticentre trial on prevention of postoperative thrombosis.Br.J.Surg 1986;73:204–8.Bergqvist 1986 BBergqvist D, Burmark US, Frisell J, Hallbook T, L<strong>in</strong>dblad B, RisbergB, et al. Prospective double-bl<strong>in</strong>d comparison between Fragm<strong>in</strong><strong>and</strong> conventional low-dose hepar<strong>in</strong>: thromboprophylactic effect <strong>and</strong>bleed<strong>in</strong>g complications. Haemostasis 1986;16 Suppl:2:11–8.Bergqvist 1988 BBergqvist D, Matzsch T, Burmark US, Frisell J, Guilbaud O, HallbookT, et al. Low molecular weight hepar<strong>in</strong> given the even<strong>in</strong>g be<strong>for</strong>esurgery compared with conventional low-dose hepar<strong>in</strong> <strong>in</strong> preventionof thrombosis [published erratum appears <strong>in</strong> Br J Surg 1988 Nov;75(11):1077]. Br J Surg 1988;75(11):888–91.Bergqvist 1990 BBergqvist D, Burmark US, Frisell J, Guilbaud O, Hallbook T, HornA, et al. Thromboprophylactic effect of low molecular weight hepar<strong>in</strong>started <strong>in</strong> the even<strong>in</strong>g be<strong>for</strong>e elective general abdom<strong>in</strong>al surgery: acomparison with low-dose hepar<strong>in</strong>. Sem<strong>in</strong> Thromb Hemost 1990;16Suppl.:19–24.Bergqvist 1992Bergqvist D, L<strong>in</strong>dgren B, Matzsch T. Glycosam<strong>in</strong>noglycans <strong>in</strong> prophylaxisaga<strong>in</strong>st venous thromboembolism. Adv Exp Med Biol 1992;313:259–74.Bergqvist 1995Bergqvist D, Burmark US, Flordal PA, Frisell J, Hallbook T, HedbergM, et al. Low molecular weight hepar<strong>in</strong> started be<strong>for</strong>e surgery asprophylaxis aga<strong>in</strong>st deep ve<strong>in</strong> thrombosis: 2500 versus 5000 XaI units<strong>in</strong> 2070 patients. British Journal of Surgery 1995;82:496–501.Bergqvist 1996Bergqvist D, Flordal PA, Friberg B, Frisell J, Hedberg M, LjungstromKG, et al. Thromboprophylaxis with a low molecular weight hepar<strong>in</strong>(t<strong>in</strong>zapar<strong>in</strong>) <strong>in</strong> emergency abdom<strong>in</strong>al surgery. A double-bl<strong>in</strong>d multicentertrial. Vasa 1996;25:156–60.Boneu 1993Boneu B. An <strong>in</strong>ternational multicentre study: Clivar<strong>in</strong> <strong>in</strong> the preventionof venous thromboembolism <strong>in</strong> patients undergo<strong>in</strong>g generalsurgery. Report of the International Clivar<strong>in</strong> Assessment Group..Blood Coagul Fibr<strong>in</strong>olysis 1993;4 Suppl 1:S21–2.Borow 1983Borow M, Goldson HJ. Prevention of Postoperative Deep VenousThrombosis <strong>and</strong> Pulmonary Emboli with Comb<strong>in</strong>ed Modalities. AmSurg 1983;49:599–605.Bredd<strong>in</strong> 1983Bredd<strong>in</strong> K, Har<strong>in</strong>g R, Koppenhagen K. Prevention of postoperativethrombotic complications with hepar<strong>in</strong> <strong>and</strong> dihydroergotam<strong>in</strong>e. Ar<strong>and</strong>omized double-bl<strong>in</strong>d study. Dtsch Med Wochenschr 1983;108:98–102.Buttermann 1977Buttermann G, Theis<strong>in</strong>ger W, Weidenbach A, Hartung R, WelzelD, Pabst HW. [Quantitative assessment of drug-<strong>in</strong>duced prophylaxisof postoperative thromboembolism. Comparison of frequencies ofdeep ve<strong>in</strong> thrombosis <strong>and</strong> pulmonary embolism us<strong>in</strong>g acetylsalicylicacid,dextran, dihydroergotam<strong>in</strong>e, low-dose hepar<strong>in</strong> <strong>and</strong> the fixedcomb<strong>in</strong>ation of hepar<strong>in</strong> <strong>and</strong> dihydroergotam<strong>in</strong>e (author’s transl)].Med Kl<strong>in</strong> 1977;72:1624–38.Cade 1987Cade JF, Wood M, Magnani HN, Westlake GW. Early cl<strong>in</strong>ical experienceof a new hepar<strong>in</strong>oid, Org 10172, <strong>in</strong> prevention of deep venousthrombosis. Thromb Res 1987;45:497–503.Caen 1988Caen JP. A r<strong>and</strong>omized double-bl<strong>in</strong>d study between a low molecularweight hepar<strong>in</strong> Kabi 2165 <strong>and</strong> st<strong>and</strong>ard hepar<strong>in</strong> <strong>in</strong> the prevention ofdeep ve<strong>in</strong> thrombosis <strong>in</strong> general surgery. A French multicenter trial.Thromb Haemost 1988;59:216–20.Comerota 1986 BComerota AJ, White JV. The use of dihydroergotam<strong>in</strong>e <strong>and</strong> hepar<strong>in</strong><strong>in</strong> the prophylaxis of deep venous thrombosis. Chest 1986;89:389S–95S.Creperio 1990Creperio G, Marab<strong>in</strong>i M, Ciocia G, Bergonzi M, F<strong>in</strong>cato M. [Evaluationof the effectiveness <strong>and</strong> safety of Fragm<strong>in</strong> (Kabi 2165) versuscalcium hepar<strong>in</strong> <strong>in</strong> the prevention of deep venous thrombosis <strong>in</strong>general surgery]. M<strong>in</strong>erva Chir 1990;45:1101–6.EFS 1988The European Fraxipar<strong>in</strong> Study (EFS) Group. Comparison of a lowmolecular weight hepar<strong>in</strong> <strong>and</strong> unfractionated hepar<strong>in</strong> <strong>for</strong> the preventionof deep ve<strong>in</strong> thrombosis <strong>in</strong> patients undergo<strong>in</strong>g abdom<strong>in</strong>alsurgery. The European Fraxipar<strong>in</strong> Study (EFS) Group. Br J Surg1988;75:1058–63.Encke 1988Encke A. Comparison of a low molecular weight hepar<strong>in</strong> <strong>and</strong> unfractionatedhepar<strong>in</strong> <strong>for</strong> the prevention of deep ve<strong>in</strong> thrombosis <strong>in</strong>patients undergo<strong>in</strong>g abdom<strong>in</strong>al surgery. Br J Surg 1988;75:1058–63.Enoxacan 1997Enoxacan Study Group. Efficacy <strong>and</strong> safety of enoxapar<strong>in</strong> versus unfractionatedhepar<strong>in</strong> <strong>for</strong> prevention of deep ve<strong>in</strong> thrombosis <strong>in</strong> electivecancer surgery: a double-bl<strong>in</strong>d r<strong>and</strong>omized multicentre trial withvenographic assessment. ENOXACAN Study Group. Br J Surg 1997;84:1099–103.Garcea 1992Garcea D, Martuzzi F, Santelmo N, Savoia M, Casertano MG, FurnoA, et al. Post-surgical deep ve<strong>in</strong> thrombosis prevention: evaluation<strong>Hepar<strong>in</strong>s</strong> <strong>and</strong> <strong>mechanical</strong> <strong>methods</strong> <strong>for</strong> <strong>thromboprophylaxis</strong> <strong>in</strong> colorectal surgery (Review)Copyright © 2006 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd8

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!